Blue Jet Healthcare Limited (BLUEJET) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Blue Jet Healthcare Limited (BLUEJET) has a cash flow conversion efficiency ratio of 0.165x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.07 Billion ≈ $22.41 Million USD) by net assets (Rs12.56 Billion ≈ $135.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Blue Jet Healthcare Limited for the company's overall valuation and market capitalisation.
Blue Jet Healthcare Limited - Cash Flow Conversion Efficiency Trend (2020–2026)
This chart illustrates how Blue Jet Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Blue Jet Healthcare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Blue Jet Healthcare Limited ranked by their cash flow conversion efficiency. Explore earnings quality score of Blue Jet Healthcare Limited to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FuelCell Energy Inc
NASDAQ:FCEL
|
-0.037x |
|
Hbt Financial Inc
NASDAQ:HBT
|
0.032x |
|
Hunan Heshun Petroleum Co Ltd
SHG:603353
|
0.132x |
|
Ningbo Fujia Industrial Co Ltd
SHG:603219
|
0.020x |
|
Jiangsu Bojun Industrial Technology Co. Ltd
SHE:300926
|
0.019x |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
0.018x |
|
E2open Parent Holdings Inc
NYSE:ETWO
|
0.046x |
|
Iovance Biotherapeutics Inc
NASDAQ:IOVA
|
-0.112x |
Annual Cash Flow Conversion Efficiency for Blue Jet Healthcare Limited (2020–2026)
The table below shows the annual cash flow conversion efficiency of Blue Jet Healthcare Limited from 2020 to 2026. View Blue Jet Healthcare Limited (BLUEJET) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs13.60 Billion ≈ $147.07 Million |
Rs3.38 Billion ≈ $36.56 Million |
0.249x | +515.48% |
| 2025-03-31 | Rs11.33 Billion ≈ $122.54 Million |
Rs457.65 Million ≈ $4.95 Million |
0.040x | -85.85% |
| 2024-03-31 | Rs8.45 Billion ≈ $91.41 Million |
Rs2.41 Billion ≈ $26.09 Million |
0.285x | +37.42% |
| 2023-03-31 | Rs6.81 Billion ≈ $73.70 Million |
Rs1.42 Billion ≈ $15.31 Million |
0.208x | -26.01% |
| 2022-03-31 | Rs5.22 Billion ≈ $56.40 Million |
Rs1.46 Billion ≈ $15.83 Million |
0.281x | -26.57% |
| 2021-03-31 | Rs3.40 Billion ≈ $36.75 Million |
Rs1.30 Billion ≈ $14.05 Million |
0.382x | -36.84% |
| 2020-03-31 | Rs2.03 Billion ≈ $21.93 Million |
Rs1.23 Billion ≈ $13.27 Million |
0.605x | -- |
About Blue Jet Healthcare Limited
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance… Read more